Skip to main content
    T

    Terns Pharmaceuticals Inc (TERN)

    Official site

    BIOTECHNOLOGY

    $52.95
    +0.00 (+0.00%)

    Last updated: May 05, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    82%(18/22)
    Avg Surprise
    -140.44%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$-0.28
    Range$-0.34 - $-0.24
    3 analysts
    EPS Revisions
    1
    0
    7d
    3
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.32+12.6%
    60d ago$-0.30+8.5%
    30d ago$-0.29+3.4%
    7d ago$-0.28+2.9%
    Current$-0.28
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    Last 12 of 22 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jun 26EST
    		-$-0.28$-0.34 - $-0.24--3
    3
    1
    30d
    		-
    Mar 26
    Reported Mar 31
    		$-0.24$-0.26$-0.32 - $-0.22+9.04%Beat3
    2
    1
    30d
    		+7.9%
    Dec 25
    Reported Mar 31
    		$-0.24$-0.30$-0.33 - $-0.21+19.97%Beat9
    1
    2
    30d
    		+0.0%
    Sep 25
    Reported Nov 10
    		$-0.27$-0.30$-0.32 - $-0.27+10.63%Beat10
    3
    1
    30d
    		+3.6%
    Jun 25
    Reported Aug 5
    		$-0.26$-0.29$-0.31 - $-0.27+10.90%Beat7
    1
    3
    30d
    		+16.1%
    Mar 25
    Reported May 12
    		$-0.26$-0.27$-0.29 - $-0.26+3.77%Beat4
    No revisions (30d)
    		+13.3%
    Dec 24
    Reported Mar 12
    		$-0.24$-0.30$-0.36 - $-0.27+20.05%Beat8
    1
    0
    30d
    		+17.2%
    Sep 24
    Reported Nov 12
    		$-0.28$-0.32$-0.37 - $-0.30+12.50%Beat9
    1
    0
    30d
    		+33.3%
    Jun 24
    Reported Aug 5
    		$-0.31$-0.34$-0.38 - $-0.32+8.82%Beat7
    No revisions (30d)
    		-24.0%
    Mar 24
    Reported May 13
    		$-0.30$-0.34$-0.41 - $-0.29+11.76%Beat8
    No revisions (30d)
    		+3.2%
    Dec 23
    Reported Mar 14
    		$-0.29$-0.29$-0.32 - $-0.26+0.00%Beat9
    1
    0
    30d
    		+0.0%
    Sep 23
    Reported Nov 14
    		$-0.42$-0.31$-0.38 - $-0.25-35.48%Miss9
    No revisions (30d)
    		+4.5%
    Jun 23
    Reported Aug 8
    		$-0.25$-0.34$-0.42 - $-0.30+26.47%Beat9
    No revisions (30d)
    		+54.5%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$52.91
    SMA 20$52.80
    SMA 50$49.45
    SMA 200$27.99
    EMA 10$52.89
    EMA 20$52.45
    EMA 50$49.19
    EMA 200$32.56

    MACD

    Line: 0.90Signal: 1.20Hist: -0.30

    ADX

    ADX: 49.6+DI: 29.5-DI: 9.0

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down20.0
    PSAR$53.00

    Bollinger Bands

    Upper Band$53.07
    Lower Band$52.52
    %B Position103%(Upper)
    Band Width0.78

    RSI (14-Day)

    Overbought
    73.9

    Momentum Oscillators

    Stoch %K91.0
    Stoch %D89.8
    Williams %R-8.1
    ROC (10d)0.2%
    Momentum0.09
    CCI (20d)86.3
    MFI (14d)71.2

    Volatility Measures

    ATR (14d)$0.40(0.7%)
    StdDev (20d)0.14
    Hist Vol1.6%(Low)

    Volume Flow

    VWAP$52.95
    OBV194.9M
    AD Line58.4M
    CMF (20d)-0.083

    Volume Metrics

    Avg Vol (20d)4.8M
    Vol RatioN/A
    VWMA (20d)$52.74

    Pivot Points

    R3$53.01
    R2$53.00
    R1$52.97
    Pivot Point$52.96
    S1$52.93
    S2$52.92
    S3$52.89

    Advanced Oscillators

    TSI48.19
    Ultimate Osc48.0
    KST68.91

    Financial Data

    QuarterDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$0$0$0$0$0$0$0$0$1.32M$0$0$0
    Cost of Revenue$-108,000$0$0$0N/A$0$0$0$220,000$0$0$0
    Gross Profit$108,000$0$0$0N/A$0$0$0$1.10M$0$0$0
    Operating Expenses$27.60M$27.72M$27.38M$27.43M$25.95M$24.94M$25.54M$25.45M$24.06M$33.18M$21.16M$24.16M
    R&D$18.90M$19.92M$20.35M$18.72M$18.00M$15.17M$18.35M$18.59M$17.46M$14.83M$14.15M$17.06M
    SG&A$8.70M$7.80M$7.03M$8.71M$7.95M$9.77M$7.18M$6.86M$6.60M$18.35M$7.01M$7.10M
    Operating Income$-27,598,000$-27,716,000$-27,383,000$-27,427,000$-25,949,000$-24,939,000$-25,537,000$-25,446,000$-24,058,000$-33,184,000$-21,159,000$-24,157,000
    Interest Income$4.46M$3.14M$3.35M$3.64M$4.14M$3.09M$2.88M$3.18M$3.33M$3.48M$3.40M$2.69M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-23,188,000$-24,589,000$-24,029,000$-23,820,000$-21,759,000$-21,883,000$-22,675,000$-22,276,000$-20,970,000$-29,709,000$-17,824,000$-21,468,000
    Income Tax Expense$383,000$46,000$64,000$88,000$40,000$62,000$61,000$97,000$49,000$58,000$72,000$60,000
    Net Income$-23,571,000$-24,635,000$-24,093,000$-23,908,000$-21,799,000$-21,945,000$-22,736,000$-22,373,000$-21,019,000$-29,767,000$-17,896,000$-21,528,000
    EBITDA$-27,532,000$-27,484,000$-27,406,000$-27,294,000$-23,798,000$-26,655,000$-25,311,000$-25,222,000$-24,083,000$-32,967,000$-21,002,000$-23,939,000
    EBIT$-27,645,000$-27,730,000$-27,379,000$-27,463,000$-25,902,000$-24,971,000$-25,551,000$-25,458,000$-24,303,000$-33,189,000$-21,219,000$-24,161,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TERN

    News

    No news available

    Company news will appear here when available

    TERN Competitors

    CompanyTicker
    Crispr Therapeutics AGCRSP
    Diversified Healthcare TrustDHCNL
    Lifestance Health Group IncLFST
    Option Care Health IncOPCH
    Cogent Biosciences IncCOGT
    Travere Therapeutics IncTVTX
    LivaNova PLCLIVN
    Erasca IncERAS

    Sector: Healthcare

    TERN Bull Case vs Bear Case

    Bull case

    • TERN beat EPS estimates in 100.0% of its last 8 reported quarters.

    TERN Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    12.4%
    EPS estimate (fiscal period ending Jun 30, 2026)
    $-0.28
    Estimate revisions (30 days, fiscal period ending Jun 30, 2026)
    3 up, 1 down

    TERN ETF Holders

    GNG tracks 4 ETFs that hold TERN. The largest weights:

    1. BlackRock Health Sciences Trust (BME), 0.32% of the fund
    2. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.07% of the fund
    3. iShares Russell 2000 ETF (IWM), 0.02% of the fund
    4. Vanguard Extended Market Index Fund ETF Shares (VXF), 0.01% of the fund
    Open the ETF Stock Exposure tool for TERN

    See insider activity

    Frequently Asked Questions About TERN

    Does TERN pay dividends?

    Terns Pharmaceuticals Inc (TERN) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In